Yan Zhao

发表

Studies on immunoregulatory and anti-tumor activities of a polysaccharide from Salvia miltiorrhiza Bunge.

D. Fan, G. Han, X. Qi, 2013, Carbohydrate polymers.

3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before TACE: comparing single-lesion vs. multi-lesion imaging biomarkers as predictors of patient survival

J. H. Sohn, B. Hamm, J. Geschwind, 2016, European Radiology.

Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?

J. H. Sohn, J. Geschwind, MingDe Lin, 2017, Radiology.

Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL?

S. Kabus, J. Geschwind, MingDe Lin, 2018, CardioVascular and Interventional Radiology.

Pivotal study of iodine-131-labeled chimeric tumor necrosis treatment radioimmunotherapy in patients with advanced lung cancer.

Clive R. Taylor, L. Khawli, Changying Jiang, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of postmastectomy radiotherapy on T1-2N1M0 triple-negative breast cancer

Yan Zhao, Lin-Yu Xia, Wei-yun Xu, 2021, PloS one.

Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma

J. Geschwind, J. Chapiro, R. Duran, 2015, CardioVascular and Interventional Radiology.

The impact of antiangiogenic therapy combined with Transarterial Chemoembolization on enhancement based quantitative tumor response assessment in patients with hepatocellular carcinoma.

J. Duncan, John Treilhard, B. Hamm, 2017, Clinical imaging.

Drug‐related adverse events may predict efficacy in sorafenib therapy for hepatocellular carcinoma

D. Fan, G. Han, X. Qi, 2012, Hepatology.

Three-Dimensional Quantitative Tumor Response and Survival Analysis of Hepatocellular Carcinoma Patients Who Failed Initial Transarterial Chemoembolization: Repeat or Switch Treatment?

C. Georgiades, K. Hong, R. Duran, 2022, Cancers.

Early response assessment of intraarterial therapy using 3D quantitative tumour enhancement analysis on MRI in patients with liver metastases from renal cell carcinoma

J. Geschwind, J. Chapiro, R. Duran, 2015 .

The Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial Chemoembolization

D. Fan, G. Han, H. Cai, 2016, Scientific Reports.

Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: A propensity score matching study

G. Han, W. Bai, Z. Yin, 2013, Journal of digestive diseases.

Management of hepatocellular carcinoma: an overview of major findings from meta-analyses

G. Han, X. Qi, Xiaozhong Guo, 2016, Oncotarget.

Long-term oncological outcomes in laparoscopic versus open gastrectomy for advanced gastric cancer: A meta-analysis of high-quality nonrandomized studies.

Qingchuan Zhao, Yan Zhao, Zheng-yan Li, 2019, American journal of surgery.

Laparoscopic versus open gastrectomy for high-risk patients with gastric cancer: A systematic review and meta-analysis.

Qingchuan Zhao, Yan Zhao, Zheng-yan Li, 2019, International journal of surgery.

Severity of complications and long-term survival after laparoscopic total gastrectomy with D2 lymph node dissection for advanced gastric cancer: A propensity score-matched, case-control study.

Qingchuan Zhao, Yan Zhao, Zheng-yan Li, 2018, International journal of surgery.

Improved Visibility of Metastatic Disease in the Liver During Intra-Arterial Therapy Using Delayed Arterial Phase Cone-Beam CT

J. Geschwind, J. Chapiro, R. Duran, 2016, CardioVascular and Interventional Radiology.

Transarterial chemoembolization in hepatocellular carcinoma with vascular invasion or extrahepatic metastasis: A systematic review

D. Fan, G. Han, X. Qi, 2013, Asia-Pacific journal of clinical oncology.

Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosis

D. Fan, G. Han, X. Qi, 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

Traditional Chinese medicine of Xiao-Chaihu-Decoction and radical surgery predicts improved prognostic outcomes in primary liver cancer patients

Yan Zhao, Lanxiu Yang, Hai-peng Yu, 2017 .

Validation of the Hong Kong Liver Cancer Staging System in Determining Prognosis of the North American Patients Following Intra‐arterial Therapy

J. Geschwind, C. Frangakis, J. Chapiro, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Early sorafenib‐related adverse events predict therapy response of TACE plus sorafenib: A multicenter clinical study of 606 HCC patients

R. Duran, D. Fan, Zhuoli Zhang, 2016, International journal of cancer.

Combination Therapy of Sorafenib and TACE for Unresectable HCC: A Systematic Review and Meta-Analysis

G. Han, X. Qi, Lei Liu, 2014, PloS one.

mRECIST response combined with sorafenib‐related adverse events is superior to either criterion alone in predicting survival in HCC patients treated with TACE plus sorafenib

D. Fan, Zhuoli Zhang, G. Han, 2017, International journal of cancer.

Response assessment for HCC patients treated with repeated TACE: The optimal time-point is still an open issue.

G. Han, W. Bai, Yan Zhao, 2015, Journal of hepatology.

Transarterial Chemoembolization for the Treatment of Advanced-Stage Hepatocellular Carcinoma

T. Pawlik, J. Geschwind, J. Chapiro, 2016, Journal of Gastrointestinal Surgery.

Transarterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Prognostic Factors in a Single-Center Study of 188 Patients

D. Fan, G. Han, X. Qi, 2014, BioMed research international.

EASL- and mRECIST-Evaluated Responses to Combination Therapy of Sorafenib with Transarterial Chemoembolization Predict Survival in Patients with Hepatocellular Carcinoma

D. Fan, G. Han, J. Xia, 2014, Clinical Cancer Research.

Imaging , Diagnosis , Prognosis EASL-and mRECIST-Evaluated Responses to Combination Therapy of Sorafenib with Transarterial Chemoembolization Predict Survival in Patients with Hepatocellular Carcinoma

D. Fan, G. Han, J. Xia, 2014 .

Development and validation of a prognostic nomogram for gastrointestinal stromal tumors in the postimatinib era: A study based on the SEER database and a Chinese cohort.

Hao Wang, Y. Nie, Jianjun Yang, 2023, Cancer medicine.

Sorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma: a large-scale multicenter study of 222 patients.

D. Fan, Zhuoli Zhang, G. Han, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Transarterial chemoembolization in hepatocellular carcinoma with vascular invasion or extrahepatic metastasis: A systematic review

D. Fan, G. Han, X. Qi, 2013, Asia-Pacific journal of clinical oncology.